Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05632965
Other study ID # TFPTI
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 17, 2023
Est. completion date December 15, 2023

Study information

Verified date February 2023
Source Assiut University
Contact Hanaa Abdellatif, Professor
Phone 01064747613
Email Hanaa.hassan1@med.au.edu.eg
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Thyroid hormones are the cornerstones of a complex system that plays an important role in the growth and development of children, especially in the development of the nervous system and brain. Therefore, even minimal disruptions of this system can cause permanent damage. Thyroid dysfunction is a common problem in pre-term infants. Hypothyroxinemia of prematurity within the first month of life may represent important prognostic information about morbidity and mortality. Thyroid hormone synthesis may be disrupted in co-morbid conditions . worsening the metabolism of premature infants and causing higher hormone levels compared to healthy infants.


Description:

The most common thyroid function disorder in premature infants is physiological hypothyroxinemia, followed by hypothyroidism of non-thyroidal causes. In pre-maturity, several factors can inhibit the conversion of peripheral T4 to T3, including hypoxemia, acidosis, infections, hypoglycemia, hypocalcemia and malnutrition . Some rare conditions include transient secondary/tertiary hypothyroidism, transient primary hypothyroidism and permanent primary hypothyroidism. Thyroid dysfunction has been reported to be more common in infants with low birth weight due to inadequate intrauterine nutrition, hypoxia, and acidosis.In addition, a meta-analysis found that birth weight and gestation week age closely related to thyroid function tests. Plasma T4, FT4, T3, rT3, (thyroid stimulating hormone), and (thyroxin binding globulin) concentrations during the first 8 weeks after birth in infants of 28-30 weeks gestation and in infants of <28 weeks gestation.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date December 15, 2023
Est. primary completion date November 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Days to 10 Days
Eligibility Inclusion Criteria: - All preterm infants (<37w gestational age) admitted to NICU unit of assiut university children hospital with various problems as : •respiratory distress - hypoxia - sepsis - necrotizing enterocolitis - receiving TPN (total parental nutrition) - infants presented with jaundice. - Another group of healthy preterm of comparable gestational age not complaining from any problems coming to routine postnatal checkup and outpatient clinic of neonatal unit will be taken . Exclusion Criteria: - preterm infants with : • fetal congenital malformations.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Egypt Heba Ali Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Thyroid function TSH level free T3 freeT4 10 days
See also
  Status Clinical Trial Phase
Not yet recruiting NCT01682785 - Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder N/A
Completed NCT04470440 - Thyroid Dysfunction and Nivolumab Reponse in NSCLC
Not yet recruiting NCT04809454 - Frequency of Florid Hyperthyroidism In Patients Taking Iodinated Salt
Recruiting NCT05980923 - Thyroid Profiles in Patients With Acute Illness
Recruiting NCT03754621 - Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
Not yet recruiting NCT04323007 - Thyroid Dysfunction in Patients With Nephrotic Syndrome N/A
Completed NCT04013308 - Iontophoresis With Potassium Iodide and Thyroid Function N/A
Completed NCT05385029 - Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19
Not yet recruiting NCT06293534 - Thyroid Dysfunction in Patients With Major Psychiatric Disorders
Terminated NCT03787303 - Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma Phase 2
Completed NCT02832934 - The TRUST Study - CardioVascular Imaging IMT Phase 4
Completed NCT02832960 - The TRUST Trial - CardioVascular Imaging ECHO Phase 4
Completed NCT00592514 - Thyroid Dysfunction in Head and Neck Surgery Patients N/A
Terminated NCT00504218 - Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients
Active, not recruiting NCT04658524 - Evaluation of Thyroid Function in Patients With Chronic Kidney Disease
Completed NCT02500342 - Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism Phase 4
Completed NCT02491008 - Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction Phase 4
Not yet recruiting NCT06185309 - Evaluation of Different Psychiatric Symptoms in Patients With Thyroid Dysfunction
Not yet recruiting NCT04613323 - Management of Thyroid Function in Hashimoto's Thyroiditis During Pregnancy
Recruiting NCT04019509 - The Influence of Different Thyroid Autoantibodies on Thyroid Function and Pregnancy Outcome After Assisted Reproductive Technology N/A